^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Fallopian Tube Cancer |
| Drug: | carboplatin (Tubulin polymerization promoter) + pegylated liposomal doxorubicin (Topoisomerase II inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Fallopian tube cancer: Other Recommended Regimen…Carboplatin/Liposomal Doxorubicin
